Damaira Pharmaceuticals Private Limited

Damaira Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24230CH2020PTC043119 Incorporated 29 July 2020 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹82.77 Cr
▲ 229% YoY
Net profit · FY 2025
₹71.73 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹7.66 Cr
EBITDA margin 9.3%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹7 Cr
Issued & subscribed
Open charges
₹46.9 Cr
Satisfied ₹18.5 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
104
Provident fund records

About Damaira Pharmaceuticals Private Limited

Data last updated:

Damaira Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2020PTC043119. Its GSTIN is 04AAHCD8720E1ZX (Chandigarh).

The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹7 Cr. It is led by directors including Vikul Bansal (Managing Director) and Manik Bansal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO 321 – 322 Sector – 35 B, Chandigarh, India – 160022.

As per the financials filed for FY 2025, the company reported a revenue of ₹82.77 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹71.73 Lakh (net margin 0.9%) and EBITDA of ₹7.66 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 645% over three years.

The company has about 104 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Damaira. As per MCA filings, the company has open charges of ₹46.9 Cr and satisfied charges of ₹18.5 Cr on record.

Damaira Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0019761). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230CH2020PTC043119
Registration Number 043119
Incorporation Date 29 July 2020
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0019761
Key People
Vikul Bansal Managing Director Ashish Sharma Additional Director Manik Bansal Director

Recognitions & Rankings of Damaira Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-CH-01-0019761

Contact details

Damaira Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    SCO 321 – 322 Sector – 35 B, Chandigarh, India – 160022
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Damaira Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Damaira Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Damaira Pharmaceuticals operates one associated brand: Damaira. Each brand links to its own profile.

BrandDescriptionWebsite
Damaira
Manufactures Carbapenem dry powder injections for treating severe and complicated bacterial infections.damaira.com

Business activity

The main business activity of Damaira Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Damaira Pharmaceuticals Private Limited, buy the company report.

Financials of Damaira Pharmaceuticals Private Limited

FY 2024 filings available

Damaira Pharmaceuticals Private Limited reported revenue of ₹82.77 Cr (up 229% YoY) for FY 2025.

Revenue · FY 2025
₹82.77 Cr ▲ 229%
Net profit · FY 2025
₹71.73 Lakh margin 0.9%
EBITDA · FY 2025
₹7.66 Cr margin 9.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 229%
3 years · compounded
▲ 645%
EBITDA CAGR growth
1 year
▲ 565%
3 years · compounded
▲ 137%

Revenue has grown at a compounded annual rate (CAGR) of 645% over three years, including 229% growth in the latest year. EBITDA rose 565% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹71.73 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.3%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Damaira Pharmaceuticals Private Limited, buy the company report.

Board of directors of Damaira Pharmaceuticals Private Limited

Damaira Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashish SharmaAdditional Director13 Nov 20233 Years 0 MonthsCurrent
Manik BansalDirector08 Dec 20223 Years 11 MonthsCurrent
Vikul Bansal
Also directs: Aura Collective Private Limited, Hermera Enterprise Private Limited, Shamroha Lifesciences Private Limited
Managing Director29 Jul 20206 Years 3 MonthsCurrent
View all directors

Auditor

Damaira Pharmaceuticals Private Limited is audited by A A R S H & Associates Chartered Accountants for the financial year 2024.

Auditor firmFinancial yearFirm registration number
A A R S H & Associates Chartered AccountantsFY 20240024177N

Shareholding

The shareholding of Damaira Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Damaira Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹46.9 Cr
Satisfied charges
₹18.5 Cr
Breakdown by lending institutions
Others₹34.90 Cr
Hdfc Bank Limited₹12.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Dec 2024101032856Hdfc Bank Limited₹12 CrOpen
26 Dec 2022100684217Others₹34.9 CrOpen
13 Dec 2021100514073Others₹18.5 CrSatisfied

To see the full charge records of Damaira Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Damaira Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Damaira Pharmaceuticals Private Limited has a workforce of 104 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
104
Active EPFO establishments
1
Employee growth
2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27104
FY 2025-26
FY 2024-25
FY 2023-24

To see the full employee and EPFO history of Damaira Pharmaceuticals Private Limited, buy the company report.

GST

Damaira Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AAHCD8720E1ZXChandigarhActive08 Apr 2021

To see the full GST registrations and return filing status of Damaira Pharmaceuticals Private Limited, buy the company report.

Recent activity

Damaira Pharmaceuticals Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Ashish Sharma was appointed as Additional Director on 13 Nov 2023.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.00 Cr with Charge ID 101032856 was registered on 23 Dec 2024.
Charges
A charge with Others of Rs. 34.90 Cr registered on 26 Dec 2022 with Charge ID 100684217 was modified on 26 Oct 2024.
AGM
Damaira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Damaira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Appointed
Ashish Sharma was appointed as Additional Director.
Ceased
Vikul Bansal ceased to be Director.
Charges
A charge with Others amounted to Rs. 34.90 Cr with Charge ID 100684217 was registered on 26 Dec 2022.
Charges
A charge registered on 13 Dec 2021 via Charge ID 100514073 with Others was fully satisfied on 26 Dec 2022.
Appointed
Manik Bansal was appointed as Director.
Ceased
Bhagwat Bansal ceased to be Director.
Charges
A charge with Others amounted to Rs. 18.50 Cr with Charge ID 100514073 was registered on 13 Dec 2021.
Appointed
Vikul Bansal was appointed as Managing Director.

1 earlier event is in the company report.

Frequently asked questions

Damaira Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2020 (6+ years old) and is registered under CIN U24230CH2020PTC043119.

Damaira Pharmaceuticals has 3 current directors:

The latest financial statements of Damaira Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Damaira Pharmaceuticals is 04AAHCD8720E1ZX, registered in Chandigarh.

The CIN (Corporate Identification Number) of Damaira Pharmaceuticals is U24230CH2020PTC043119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Damaira Pharmaceuticals was incorporated on 29 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.

Ashish Sharma was appointed as Additional Director on 13 Nov 2023. Vikul Bansal ceased to be Director on 28 Mar 2023. Manik Bansal was appointed as Director on 08 Dec 2022. Damaira Pharmaceuticals has 5 board changes on record in total.

Yes, Damaira Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0019761).

The registered office of Damaira Pharmaceuticals is at SCO 321 – 322 Sector – 35 B, Chandigarh, India – 160022.

Damaira Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.